Bausch Health Companies Inc. Common Stock (BHC)
R&D Expenses
$634.00M
TTM · Period ending: · USD
BHC R&D Expenses
Latest reported$634.00Mperiod ending
Latest reported$634.00Mperiod ending
BHC R&D Expenses ($0.00 → $634.00M)
Annual R&D Expenses
High-resolution chart · PNG
BHC r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 629,000,000 | |
| 634,000,000 | |
| 604,000,000 | |
| 530,000,000 | |
| 473,000,000 | |
| 485,000,000 | |
| 516,000,000 | |
| 442,000,000 | |
| 369,000,000 | |
| 469,000,000 | |
| 440,000,000 | |
| 266,000,000 | |
| 156,800,000 | |
| 79,100,000 | |
| 174,887,000 | |
| 157,556,000 | |
| 14,148,000 | |
| 92,844,000 | |
| 118,117,000 | |
| 95,474,000 | |
| 88,884,000 | |
| 72,500,000 | |
| 86,570,000 | |
| 52,150,000 | |
| 51,017,000 | |
| 52,659,000 | |
| 33,100,000 | |
| 17,500,000 | |
| 0 | |
| 7,500,000 | |
| 0 | |
| 0 | |
| 0 |